Jakub Hlávka

Jakub Hlávka, PhD, is a Research Assistant Professor in Health Policy and Management at the Schaeffer Center for Health Policy and Economics, University of Southern California, and Project Manager of a $2.3 million NIH R01 Grant focused on novel treatments for Alzheimer's and Dementia.

Dr. Hlávka's expertise lies in innovative payment approaches for healthcare, health system reform, emerging therapies, and the study of inequality, with a particular focus on Alzheimer's disease, oncology outcome measurement, and cardiovascular disease treatment.

He completed his PhD at the Pardee RAND Graduate School, where his research centered on innovative payment approaches for emerging treatments, specializing in cardiovascular conditions.

Prior to his current role, Dr. Hlávka gained professional experience at Genentech, where he was involved in R&D portfolio planning, and at Tufts Medical Center's Center for the Evaluation of Value and Risk in Health, focusing on cancer-specific outcome measures.

Beyond healthcare, he has contributed to studies in national security, aerospace, and emerging technologies, holding research and consulting roles at prestigious organizations like the Fraunhofer Society in Germany, RAND Europe in Cambridge, England, and the Czech Government and Ministry of Finance in Prague.

Dr. Hlávka's educational background includes degrees from the Pardee RAND Graduate School, Georgetown University, and the University of Economics in Prague.

He is associated with various organizations such as the Leonard D. Schaeffer Center for Health Policy and Economics, The Aspen Institute, Charles University in Prague, The National Academies of Sciences, Engineering, and Medicine, and the USC Center for Risk and Economic Analysis of Threats and Emergencies, among others.

With a diverse professional background encompassing research, consulting, academia, and public policy, Dr. Hlávka has established himself as a respected figure in the realm of health policy, economics, and healthcare innovation.